IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MANTERO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.732
NA - Nord America 2.275
AS - Asia 937
OC - Oceania 21
SA - Sud America 19
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.192
GB - Regno Unito 1.337
IT - Italia 506
CN - Cina 400
SE - Svezia 244
DE - Germania 179
SG - Singapore 156
IE - Irlanda 106
IN - India 98
RU - Federazione Russa 93
CA - Canada 78
DK - Danimarca 61
HK - Hong Kong 60
FR - Francia 49
TR - Turchia 49
ID - Indonesia 46
KR - Corea 36
UA - Ucraina 29
FI - Finlandia 26
VN - Vietnam 21
JP - Giappone 19
AU - Australia 17
CH - Svizzera 16
BE - Belgio 13
EU - Europa 13
ES - Italia 12
TH - Thailandia 12
TW - Taiwan 12
GR - Grecia 11
NL - Olanda 11
PH - Filippine 7
RO - Romania 7
BR - Brasile 6
DZ - Algeria 5
MX - Messico 5
PL - Polonia 5
AR - Argentina 4
AT - Austria 4
CO - Colombia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
LB - Libano 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RS - Serbia 4
IR - Iran 3
MY - Malesia 3
PK - Pakistan 3
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
LU - Lussemburgo 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
EE - Estonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
TG - Togo 1
UZ - Uzbekistan 1
Totale 6.009
Salva come PNG Salva come JPEG
Città #
Southend 1.283
Fairfield 294
Chandler 251
Milan 214
Houston 147
Ashburn 145
Wilmington 142
Woodbridge 136
Ann Arbor 130
Seattle 112
Cambridge 110
Dublin 101
Princeton 101
Singapore 84
Beijing 64
Dearborn 64
Toronto 58
Hong Kong 48
Des Moines 39
Jakarta 38
Nanjing 36
Hanover 34
Boardman 30
Bengaluru 28
Frankfurt am Main 25
Mountain View 25
Phoenix 24
Rome 21
Grafing 20
Shenyang 19
Berlin 18
Guangzhou 17
Hebei 17
Redmond 16
Redwood City 16
Munich 15
San Diego 15
Shanghai 15
Sunnyvale 15
Changsha 13
Hangzhou 12
Jinan 12
Jiaxing 10
Brussels 9
Chengdu 9
Genoa 9
Helsinki 9
London 9
Nanchang 9
Silver Spring 9
Turin 9
Central District 8
Hefei 8
Los Angeles 8
Naples 8
Taipei 8
Tianjin 8
Zurich 8
Lanzhou 7
Medford 7
Baltimore 6
Haikou 6
Madrid 6
Miami 6
New York 6
Nuremberg 6
Seoul 6
Wuhan 6
Zhengzhou 6
Austin 5
Bangkok 5
Bühl 5
Eitensheim 5
Fremont 5
Genova 5
Hanoi 5
Jacksonville 5
Ningbo 5
Parma 5
Sakarya 5
Yokohama 5
Athens 4
Belgrade 4
Bitonto 4
Changchun 4
Chicago 4
Como 4
Falls Church 4
Fuzhou 4
Gainesville 4
Ho Chi Minh City 4
Kent 4
Melbourne 4
Montreal 4
Ottawa 4
Pescara 4
Sydney 4
Verona 4
Barcelona 3
Brisbane 3
Totale 4.344
Salva come PNG Salva come JPEG
Nome #
Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy 605
Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy 283
Acute exacerbations of COPD : risk factors for failure and relapse 197
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis : serum inflammatory biomarkers, clinical efficacy,and microbiological eradication 196
Non-Intensive Care Unit Acquired Pneumonia : A New Clinical Entity? 189
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 189
Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection 181
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis 177
Interstitial pneumonia with autoimmune features : An additional risk factor for ARDS? 158
Proteome Investigation of Rat Lungs subjected to Ex Vivo Perfusion (EVLP) 154
COVID-19 multidisciplinary high dependency unit: the Milan model 150
Management of severe COPD exacerbations : focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide 148
Quality standards for the management of bronchiectasis in Italy : a national audit 144
The evidence on tiotropium bromide in asthma: from the rationale to the bedside 141
Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendations 140
Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease 131
COPD management as a model for all chronic respiratory conditions : report of the 4th Consensus Conference in Respiratory Medicine 127
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 123
Impact of exacerbations in the natural course of COPD 121
Application of machine learning to predict obstructive sleep apnea syndrome severity 121
Update on the management of pediatric acute osteomyelitis and septic arthritis 120
Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy 119
Mucormycosis in CAPA, a possible fungal super-infection 117
Compliance with anti-H1N1 vaccine among healthcare workers and general population 114
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 113
Effect of continuous positive airway pressure on respiratory drive in patients with obstructive sleep apnea 112
Antibiotics as immunomodulant agents in COPD 110
Vaccinazione antipneumococcica negli adulti: raccomandazioni della Società italiana di medicina respiratoria (SIMeR) e della Società italiana di igiene, medicina preventiva e Sanità pubblica (SItI)=Pneumococcal vaccination in adults: recommendations from the Italian society of respiratory medicine (SIMeR) and the Italian society of hygiene, preventicve medicine and public health (SItI) 110
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia 106
Pneumonia due to Mycoplasma, Chlamydophila and Legionella 94
Emerging antibacterial and antiviral drugs for treating respiratory tract infections 85
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 82
Knowledge and attitudes on influenza vaccination among Italian physicians specialized in respiratory infections : an Italian Respiratory Society (SIP/IRS) web-based survey 79
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients 78
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 75
Understanding the burden of pneumococcal disease in adults 74
An ounce of prevention is worth a pound of cure 73
Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease 72
Physiotherapy approach after lung transplantation in a critically ill COVID-19 patient: a case report 66
Protease–antiprotease imbalance in bronchiectasis 55
Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study 55
The role of vaccination in preventing pneumococcal disease in adults 53
Emerging biological therapies for treating chronic obstructive pulmonary disease : a pairwise and network meta-analysis 53
Time to active sitting position: One-year findings from a temporary COVID-19 intensive care unit 53
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 52
Therapeutic approach to respiratory infections in lung transplantation 51
Treatable traits in interstitial lung diseases: a call to action 50
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 49
Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey 46
Post-COVID-19 sequelae 46
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 46
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 45
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department 41
Respiratory involvement in Fabry disease 34
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 31
Walking the path of treatable traits in interstitial lung diseases 27
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 24
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 18
Use of Dupilumab in Asthma Relapse After Lung Transplant 17
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 13
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 13
Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study 12
Microbiological surveillance after lung transplantat: focus on fungi 7
null 3
null 3
null 3
null 3
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study 1
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study 1
Totale 6.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.143 0 63 58 159 84 124 148 79 196 123 54 55
2020/2021925 44 68 41 82 87 81 61 152 81 87 91 50
2021/2022771 66 50 50 39 46 50 71 51 104 72 34 138
2022/2023967 103 98 74 82 109 162 44 78 97 19 58 43
2023/2024743 22 52 36 41 158 65 55 23 28 53 79 131
2024/2025134 80 54 0 0 0 0 0 0 0 0 0 0
Totale 6.379